Cite
MLA Citation
Rebecca L. Prue et al.. “A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer.” Journal of immunotherapy, vol. 38, no. 2, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100048765224.0x00003b